Does Midbrain Atrophy Distinguish Progressive Supranuclear Palsy from Frontotemporal Dementia?
Both quantitative and qualitative measures of midbrain atrophy provided modest accuracy in distinguishing PSP from bvFTD.
Authors
- Francisco Cardoso (ORCID: https://orcid.org/0000-0003-0808-0116)
- Sarah Camargos (ORCID: https://orcid.org/0000-0001-9829-6783)
- Antônio Lúcio Teixeira (ORCID: https://orcid.org/0000-0002-9621-5422)
- Leonardo Cruz de Souza (ORCID: https://orcid.org/0000-0001-5027-9722)
- Thiago Trovati Maciel (ORCID: https://orcid.org/0000-0002-9347-981X)
- Paulo Caramelli (ORCID: https://orcid.org/0000-0002-4786-6990)
- Elisa de Paula França Resende (ORCID: https://orcid.org/0000-0002-9758-6452)
- Natália Pessoa Rocha (ORCID: https://orcid.org/0000-0003-2616-8082)
- Mauro César Quintão e Silva Cunningham
- Vinícius Ribeiro Jeunon (ORCID: https://orcid.org/0009-0004-2356-2951)
Institutions
- Universidade Federal de Minas Gerais (BR)
- The University of Texas at San Antonio Health Science Center (US)
- Technology Innovation Institute (AE)
- Faculdade de Ciências Médicas de Minas Gerais (BR)
- The University of Texas Health Science Center at Houston (US)
Publication Details
- Journal
- Movement Disorders Clinical Practice
- Published
- 2025-04-02
- DOI
- https://doi.org/10.1002/mdc3.70058
- Citations
- 3
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 4.17
Funders
- Michael J. Fox Foundation for Parkinson's Research
- Biogen
- Danone
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Novo Nordisk
- Universidade Federal de Minas Gerais